Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/8/24 16:02 | 11/7/24 | MURA | Health | Drug | Pharmaceutical Preparations | Goodman Vicki L | L2 | O | Chief Me | S | -17 | 3.33 | 0 | -5 | -7 | 68 | D | ||||||||||||||
11/1/24 07:04 | 10/31/24 | MURA | Health | Drug | Pharmaceutical Preparations | Cutler Adam D. | L2 | O | CFO | S | -25 | 3.41 | 0 | -7 | -9 | 71 | D | ||||||||||||||
7/18/24 16:04 | 7/18/24 | MURA | Health | Drug | Pharmaceutical Preparations | Keson-Brookes Maiken | L2 | O | See Rema | S | -7 | 3.41 | 0 | -2 | -5 | 44 | D | ||||||||||||||
7/8/24 20:03 | 7/8/24 | MURA | Health | Drug | Pharmaceutical Preparations | Loew Caroline | L2 | DO | CEO | S | -36 | 2.91 | 0 | -13 | -5 | 240 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |